Sun Pharma facility placed on FDA import alert
The company’s Gujarat facility has been listed under import alert, after an inspection earlier this year found it was not cGMP compliant.
The company’s Gujarat facility has been listed under import alert, after an inspection earlier this year found it was not cGMP compliant.
The company announced Phase III results showing that hemoglobin levels were increased when patients were treated with investigational oral monotherapy, iptacopan.
The company states that the new app is able to cut study start-up times for sponsors and CROs, while it can also be used by patients across various different platforms.